| Literature DB >> 33729260 |
Vincent J Vezza1, Adrian Butterworth1, Perrine Lasserre1, Ewen O Blair1, Alexander MacDonald1, Stuart Hannah1, Christopher Rinaldi2, Paul A Hoskisson3, Andrew C Ward4, Alistair Longmuir5, Steven Setford5, Eoghan C W Farmer6, Michael E Murphy7, Damion K Corrigan1.
Abstract
Accurate and rapid diagnostic tests are critical to reducing the impact of SARS-CoV-2. This study presents early, but promising measurements of SARS-CoV-2 using the ACE2 enzyme as the recognition element to achieve clinically relevant detection. The test provides a scalable route to sensitive, specific, rapid and low cost mass testing.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33729260 DOI: 10.1039/d1cc00936b
Source DB: PubMed Journal: Chem Commun (Camb) ISSN: 1359-7345 Impact factor: 6.222